 | Up a level |
Elkateb, Heba
(2021)
Design of Lipid-Based Nanocarriers for the Treatment of Human Immunodeficiency Virus (HIV).
PhD thesis, University of Liverpool.
Elkateb, Heba, Cauldbeck, Helen 
ORCID: 0000-0002-2853-8457, Niezabitowska, Edyta, Hogarth, Cameron, Arnold, Keith, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom O ORCID: 0000-0002-9273-9173
(2023)
High drug loading solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsions for the dual drug delivery of the HIV drugs darunavir and ritonavir.
JCIS Open, 11.
p. 100087.
Hogarth, Cameron, Arnold, Keith, Wright, Steve, Elkateb, Heba, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom O ORCID: 0000-0002-9273-9173
(2024)
Navigating the challenges of lipid nanoparticle formulation: the role of unpegylated lipid surfactants in enhancing drug loading and stability.
Nanoscale advances, 6 (2).
pp. 669-679.
Elkateb, Heba, Tatham, Lee M ORCID: 0000-0001-9448-8876, Cauldbeck, Helen ORCID: 0000-0002-2853-8457, Niezabitowska, Edyta, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom ORCID: 0000-0002-9273-9173
(2020)
Optimization of the Synthetic Parameters of Lipid Polymer Hybrid Nanoparticles Dual Loaded with Darunavir and Ritonavir for the Treatment of HIV.
International Journal of Pharmaceutics, 588.
p. 119794.